BG33586A3 - Method for pentahydrate of cephalosporine derivative obtaining - Google Patents

Method for pentahydrate of cephalosporine derivative obtaining

Info

Publication number
BG33586A3
BG33586A3 BG049206A BG4920680A BG33586A3 BG 33586 A3 BG33586 A3 BG 33586A3 BG 049206 A BG049206 A BG 049206A BG 4920680 A BG4920680 A BG 4920680A BG 33586 A3 BG33586 A3 BG 33586A3
Authority
BG
Bulgaria
Prior art keywords
pentahydrate
cef
acetamide
carboxylic acid
derivative obtaining
Prior art date
Application number
BG049206A
Other languages
Bulgarian (bg)
English (en)
Inventor
Alastair Brodie
Lewis Wetherill
Original Assignee
Glaxo Group Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd. filed Critical Glaxo Group Ltd.
Publication of BG33586A3 publication Critical patent/BG33586A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG049206A 1979-10-02 1980-10-01 Method for pentahydrate of cephalosporine derivative obtaining BG33586A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02

Publications (1)

Publication Number Publication Date
BG33586A3 true BG33586A3 (en) 1983-03-15

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
BG049206A BG33586A3 (en) 1979-10-02 1980-10-01 Method for pentahydrate of cephalosporine derivative obtaining

Country Status (36)

Country Link
US (1) US4329453A (it)
JP (1) JPS5657791A (it)
KR (1) KR840001776B1 (it)
AT (1) AT368161B (it)
AU (1) AU539519B2 (it)
BE (1) BE885489A (it)
BG (1) BG33586A3 (it)
CA (1) CA1142919A (it)
CH (1) CH645118A5 (it)
CS (1) CS214721B2 (it)
CY (1) CY1338A (it)
DD (1) DD153376A5 (it)
DE (1) DE3037102C2 (it)
DK (1) DK155525C (it)
EC (1) ECSP941099A (it)
ES (1) ES495534A0 (it)
FI (1) FI71157C (it)
FR (1) FR2466467A1 (it)
GB (1) GB2063871B (it)
GR (1) GR69123B (it)
HK (1) HK78686A (it)
HU (1) HU184835B (it)
IT (1) IT1144006B (it)
KE (1) KE3641A (it)
MX (1) MX6545E (it)
MY (1) MY8500315A (it)
NL (1) NL190329C (it)
NO (1) NO156246C (it)
PL (1) PL126606B1 (it)
PT (1) PT71860B (it)
RO (1) RO82721B (it)
SE (1) SE449614B (it)
SU (1) SU942599A3 (it)
UA (1) UA7208A1 (it)
YU (1) YU42357B (it)
ZA (1) ZA806081B (it)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd 7β−(2D−2−アミノ−2−カルボキシエチルチオアセトアミド)−7α−メトキシ−3−(1−メチル−1H−テトラゾ−ル−5−イル)−チオメチル−3−セフエム−4−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES8502863A1 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
EP0169700B1 (en) * 1984-07-23 1990-05-16 Eli Lilly And Company Improved pharmaceutical formulations for ceftazidime
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
EP0187450B1 (en) * 1984-11-08 1991-01-30 Eli Lilly And Company Process for the preparation of crystalline ceftazidime pentahydrate
WO1988010263A1 (en) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
DE3871542T2 (de) * 1987-02-02 1992-12-24 Lilly Co Eli Verfahren zur herstellung von ceftazidime-pentahydrat.
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
SE449614B (sv) 1987-05-11
FR2466467A1 (fr) 1981-04-10
US4329453A (en) 1982-05-11
CH645118A5 (de) 1984-09-14
MY8500315A (en) 1985-12-31
ATA490080A (de) 1982-01-15
NO802913L (no) 1981-04-03
YU249780A (en) 1983-02-28
KR840001776B1 (ko) 1984-10-19
NO156246C (no) 1987-08-19
PT71860B (en) 1982-04-02
DK155525B (da) 1989-04-17
MX6545E (es) 1985-07-10
UA7208A1 (uk) 1995-06-30
RO82721A (ro) 1984-09-29
CY1338A (en) 1987-01-16
KE3641A (en) 1986-07-11
DD153376A5 (de) 1982-01-06
GB2063871A (en) 1981-06-10
CS214721B2 (en) 1982-05-28
YU42357B (en) 1988-08-31
FI71157C (fi) 1986-11-24
IT8049783A0 (it) 1980-10-01
HU184835B (en) 1984-10-29
IT1144006B (it) 1986-10-29
DE3037102A1 (de) 1981-04-23
CA1142919A (en) 1983-03-15
JPS5657791A (en) 1981-05-20
DK414780A (da) 1981-04-03
SU942599A3 (ru) 1982-07-07
PL227019A1 (it) 1981-06-05
ZA806081B (en) 1982-05-26
HK78686A (en) 1986-10-24
DE3037102C2 (de) 1986-04-10
ES8106908A1 (es) 1981-09-01
FR2466467B1 (it) 1984-02-10
PL126606B1 (en) 1983-08-31
GR69123B (it) 1982-05-03
NL8005443A (nl) 1981-04-06
NO156246B (no) 1987-05-11
DK155525C (da) 1989-09-04
NL190329C (nl) 1994-01-17
AU539519B2 (en) 1984-10-04
KR830004317A (ko) 1983-07-09
GB2063871B (en) 1983-06-02
SE8006861L (sv) 1981-04-03
ES495534A0 (es) 1981-09-01
FI71157B (fi) 1986-08-14
RO82721B (ro) 1984-10-30
PT71860A (en) 1980-11-01
NL190329B (nl) 1993-08-16
JPH0128036B2 (it) 1989-05-31
ECSP941099A (es) 1995-01-16
FI803126L (fi) 1981-04-03
AU6288280A (en) 1981-04-09
BE885489A (fr) 1981-04-01
AT368161B (de) 1982-09-27

Similar Documents

Publication Publication Date Title
BG33586A3 (en) Method for pentahydrate of cephalosporine derivative obtaining
ES458241A1 (es) Un procedimiento para la preparacion del acido (d-alfa-ami- no-alfa-(p-hidroxifenil) acetamido) - 3 - metil-3-cefem-4- carboxilico.
AR229883A1 (es) Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
PT71946A (en) Process for preparing derivatives of 6beta-hydroxyalkylpenicillanic acids as beta-lactamase inhibitors
SE431986B (sv) Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-/(z)-2-(fur-2-yl)-2-metoxiiminoacetamido/-cef-3-em-4-karbonsyra
JPS53103493A (en) Cephalosporin derivatives and process for their preparation
IE45015L (en) Cephalosporin derivatives.
IL55186A0 (en) Crystalline form of the sodium salt of an oxime derivative 7-amino thiazolyl acetamido cephalosporanic acid,process for preparing it and the pharmaceutical compositions containing it
ES412859A1 (es) Un procedimiento para la preparacion de un derivado de 7- (alfa hidroxi-alfa-fenil) acetamido - 3 - (1 - metil - 1h - tetrazol - 5 - iltiometil) cefalosporina.
SU671732A3 (ru) Способ получени кристаллической безводной натриевой соли 7-( -2окси-2-фенилацетамидо)-3-(1-метил1н-тетразол-5-илтиометил)-3-цефем-4-карбоновой кислоты
DE3476663D1 (en) Crystalline form of ceftazidim
SE8001177L (sv) Forfarande for framstellning av natriumcefuroxim
ES8702918A1 (es) Un procedimiento para la preparacion de dihidrobromuro de acido (6r,7r)-7-((z)-2-(2-tritilaminotiazol-4-il)-2-(2-t-butiloxicarbonil-prop-2-oximino)acetamido)-3-(1piridiniometil)-3-cefem-4-carboxilico cristalino.
FR2279754A1 (fr) Procede de preparation de derives de l'acide 7-aminocephalosporanique
ATA387779A (de) Werkstoff zur pulvermetallurgischen herstellung von gegenstaenden mit hoher verschleissfestigkeit, sowie gegenstand daraus
FR2298552A1 (fr) Procede de preparation de derives d'acide 7-aminocephalosporanique
GB2012270A (en) Crystallisation process for sodium cefuroxime
SE432255B (sv) Forfarande for framstellning av esterderivat av (6r,7r)-3-karbamoyloximetyl-7-((z)-2-(fur-2-yl)-2metoxiiminoacetamido)-cef-3-em-4-karbonsyra
SE7703689L (sv) Cefalosporiner
NZ194895A (en) Non-hygroscopic sodium salt of (6r 7r)-3-acetoxymethyl-7-((z)-2(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid and pharmaceutical compositions
DE3782939D1 (de) Kristalline cephalosporinderivate.
ES8305775A1 (es) Procedimiento para la obtencion de cefalosporina 7-aca.
KR920021562A (ko) 3-피라진 유도체 치환된 세팔로스포린 화합물
DE3788279D1 (de) Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
CA959051A (en) Physical forms of the sodium salt of 7-(1h-tetrazol-1-ylacetamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl-thiomethyl)-3-cephem-4-carboxylic acid and new 7-acylated amino-3-thiolated methyl)ceph-3-em-4-carboxylic acid and their salts